Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae

APMIS

Volumn 110, Issue 9, 2002, Pages 651-657

  Lindbäck, Emma ^a   Rahman, Motiur ^b   Jalal, Shah ^a   Wretlind, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

DNA gyrase; Neisseria gonorrhoeae; Quinolone; Resistance; Topoisomerase IV

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DNA SEQUENCE; ENZYME SUBUNIT; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE HOMOLOGY;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; SEROTYPING;

EID: 0036757734     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.1100909.x     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(RR-1):1-111.
2. Bhuiyan BU, Rahman M, Miah MRA, Nahar S, Islam N, Ahmed M, et al. Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: Emergence of high-level resistance to ciprofloxacin. J Clin Microbiol 1999;37:1130-6.
3. Ison CA, Woodford PJ, Madders H, Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother 1998;42: 2919-22.
4. Ross JDC. Fluoroquinolone resistance in gonorrhoea: How, where and so what. Int J STD AIDS 1998;9:318-22.
5. Tanaka M, Matsumoto T, Kobayashi I, Uchino U, Kumazawa J. Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob Agents Chemother 1995;39:2367-70.
6. D'Costa LJ, Plummer FA, Bowmer I, Fransen L, Piot P, Ronald AR, et al. Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985;12:64-7.
7. Rahman M, Alam A, Nessa K, Hossain A, Nahar S, Datta D, et al. Etiology of sexually transmitted infections among street-based female sex workers in Dhaka, Bangladesh. J Clin Microbiol 2000;38:1244-6.
8. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997;61:377-92.
9. Lucas CE, Balthazar JT, Hagman KE, Shafer WM. The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae. J Bacteriol 1997;179:4123-8.
10. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 2000;44:2233-41.
11. Jalal S, Wretlind B. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist 1998;4:257-61.
12. Nakano M, Deguchi T, Kawamura T, Yasuda M, Kimura M, Okano Y, et al. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997;41:2289-91.
13. Ouabdesselam S, Hooper DC, Tankovic J, Soussy CJ. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob Agents Chemother 1995; 39:1667-70.
14. Mavroidi A, Tzouvelekis LS, Tassios PT, Flemetakis A, Daniilidou M, Tzelepi E. Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999. J Clin Microbiol 2000;38:3489-91.
15. Tanaka M, Nakayama H, Haraoka M, Saika T, Kobayashi I, Naito S. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J Clin Microbiol 2000;38:521-5.
16. Trees DL, Sandul AL, Whittington WL, Knapp JS. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1998;42:2103-5.
17. Trees DL, Sandul AL, Peto-Mesola V, Aplasca MR, Leng HB, Whittington WL, et al. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and United States. Antimicrob Agents Chemother 1999;12: 325-32.
18. Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Kawada Y, et al. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1996;40:2437-8.
19. Knapp J, Koumans EH. Neisseria and Branhamella. In: In Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th Ed. Washington, DC: American Society for Microbiology; 1999: 586-603.
20. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972;1: 283-8.
21. Biedenbach DJ, Schermer IH, Jones RN. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices. Diagn Microbiol Infect Dis 1997;27:1-5.
22. Kimberle CC, Murray PR. Media. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th Ed. Washington, DC: American Society for Microbiology; 1999:1687-707.
23. Bygdeman SM, Gillenius EC, Sandström EG. Comparison of two different sets of monoclonal antibodies for the serological classification of Neisseria gonorrhoeae. In: Schoolnik GK, editor. The Pathogenic Neisseriae: Proceedings of the 4th International Symposium. Washington, DC: American Society for Microbiology; 1985:31-6.
24. Sambrook J, Fritsch EF, Mantalis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989;9:16-23.
25. Chenia HY, Pillay D, Hoosen AA, Pillay B. Assessment of molecular typing methods for differentiation of Neisseria gonorrhoeae. In: The Pathogenic Neisseriae: Proceedings of the 10th International Symposium. Baltimore, Maryland: American Society for Microbiology; 1996:419-20.
26. Lau QC, Chow VT, Poh CL. Differentiation of Neisseria gonorrhoeae strains by polymerase chain reaction and restriction fragment length polymorphism of outer membrane protein IB genes. Genitourin Med 1995;71:363-6.
27. Antignac A, Kriz P, Tzanakaki G, Alonso JM, Taha MK. Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J Antimicrob Chemother 2001;47:285-96.
28. Breines DM, Ouabdesselam S, Ng EY, Tankovic J, Shah S, Soussy CJ, et al. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob Agents Chemother 1997; 41:175-9.